CFD merupakan instrumen yang rumit dan memiliki risiko tinggi kehilangan uang secara cepat karena adanya pengaruh leverage. 84% akun investor ritel mengalami kerugian saat melakukan kegiatan perdagangan CFD dengan penyedia ini. Anda harus mempertimbangkan apakah Anda memahami cara kerja CFD dan apakah Anda mampu menerima risiko tinggi kehilangan uang.
Capital Com Australia Pty Ltd Australia (Regulated by ASIC) Capital Com UK Limited Authorised and regulated by the Financial Conduct Authority (FCA) Capital Com SV Investments Limited Cyprus / EU (Regulated by CYSEC) Сlosed Joint Stock Company «FinTech Solutions» (Regulated by NBRB) Smart Forex Broker LLC Capital Com Stock and CFD Investing Ltd Seychelles (Regulated by FSA) Capital Com Online Investments Ltd (Regulated by SCB) Our Global Offices

Scan to Download iOS&Android APP

English العَرَبِيَّة Bahasa Indonesia Български Čeština Dansk Deutsch Eesti ελληνικά Español Français Hrvatski Italiano Latviešu Lietuvių Magyar Nederlands Polski Português Română Русский Slovenčina Slovenščina Suomi Svenska Tiếng Việt ไทย 简体中文 繁體中文
Anda juga dapat menghubungi kami: hubungi +44 2030978888 support@capital.com

Perdagangan vTv Therapeutics Inc. - VTVT CFD

0.73
3.95%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.06
Biaya inap posisi Long

Long position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
-0.024068%
Biaya inap posisi short

Short position overnight fee

Margin. Your investment $1,000.00
Biaya Overnight 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00
Kunjungi platform
0.001846%
Waktu biaya inap 21:00 (UTC)
Kuantitas min. yang diperdagangkan 1
Mata uang USD
Margin 20%
Bursa efek United States of America
Komisi perdagangan 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.76
Open* 0.74
1-Year Change* 19.35%
Day's Range* 0.73 - 0.76
52 wk Range 0.38-1.40
Average Volume (10 days) 66.30K
Average Volume (3 months) 2.25M
Market Cap 81.05M
P/E Ratio -100.00K
Shares Outstanding 104.58M
Revenue 2.02M
EPS -0.26
Dividend (Yield %) N/A
Beta -1.17
Next Earnings Date May 10, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 22, 2023 0.73 -0.01 -1.35% 0.74 0.76 0.73
Mar 21, 2023 0.76 0.02 2.70% 0.74 0.76 0.74
Mar 20, 2023 0.74 0.01 1.37% 0.73 0.75 0.73
Mar 17, 2023 0.74 0.00 0.00% 0.74 0.75 0.72
Mar 16, 2023 0.77 0.01 1.32% 0.76 0.77 0.75
Mar 15, 2023 0.77 0.00 0.00% 0.77 0.79 0.77
Mar 14, 2023 0.77 0.03 4.05% 0.74 0.77 0.74
Mar 13, 2023 0.74 0.04 5.71% 0.70 0.76 0.68
Mar 10, 2023 0.69 -0.08 -10.39% 0.77 0.77 0.67
Mar 9, 2023 0.78 -0.04 -4.88% 0.82 0.82 0.77
Mar 8, 2023 0.82 -0.08 -8.89% 0.90 0.90 0.81
Mar 7, 2023 0.86 -0.01 -1.15% 0.87 0.92 0.85
Mar 6, 2023 0.91 0.02 2.25% 0.89 0.92 0.79
Mar 3, 2023 0.76 -0.01 -1.30% 0.77 0.77 0.75
Mar 2, 2023 0.77 -0.04 -4.94% 0.81 0.81 0.76
Mar 1, 2023 0.79 0.00 0.00% 0.79 0.80 0.78
Feb 28, 2023 0.79 0.04 5.33% 0.75 0.79 0.75
Feb 27, 2023 0.75 -0.04 -5.06% 0.79 0.80 0.75
Feb 24, 2023 0.78 -0.01 -1.27% 0.79 0.79 0.78
Feb 23, 2023 0.82 -0.01 -1.20% 0.83 0.83 0.81

vTv Therapeutics Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total revenue 4.005 6.414 2.764 12.434 0.291
Revenue 4.005 6.414 2.764 12.434 0.291
Total Operating Expense 25.667 18.266 23.656 32.258 50.973
Selling/General/Admin. Expenses, Total 11.443 7.251 8.537 9.223 11.333
Research & Development 12.624 11.015 15.119 23.035 39.64
Operating Income -21.662 -11.852 -20.892 -19.824 -50.682
Interest Income (Expense), Net Non-Operating -0.011 -0.68 -1.774 -3.229 -2.975
Other, Net 4.057 -0.27 0.828 -0.592 -0.19
Net Income Before Taxes -17.616 -12.802 -21.838 -23.645 -53.847
Net Income After Taxes -17.731 -12.802 -21.938 -23.845 -48.8
Minority Interest 4.744 4.303 8.894 15.934 38.503
Net Income Before Extra. Items -12.987 -8.499 -13.044 -7.911 -10.297
Net Income -12.987 -8.499 -13.044 -7.911 -16.144
Income Available to Common Excl. Extra. Items -12.987 -8.499 -17.913 -8.65 -10.297
Income Available to Common Incl. Extra. Items -12.987 -8.499 -17.913 -8.65 -16.144
Diluted Net Income -12.987 -8.499 -17.913 -8.65 -16.144
Diluted Weighted Average Shares 60.7326 47.1379 30.292 12.4492 9.69325
Diluted EPS Excluding Extraordinary Items -0.21384 -0.1803 -0.59134 -0.69482 -1.06229
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -0.19671 -0.1803 -0.59134 -0.69482 -1.06229
Total Extraordinary Items -5.847
Total Adjustments to Net Income 0 -4.869 -0.739
Unusual Expense (Income) 1.6
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total revenue 2 0.009 3 0.009 0.987
Revenue 2 0.009 3 0.009 0.987
Total Operating Expense 8.481 11.118 4.603 4.679 5.267
Selling/General/Admin. Expenses, Total 5.348 5.716 2.221 2.242 2.164
Research & Development 3.133 5.402 2.382 2.437 3.103
Operating Income -6.481 -11.109 -1.603 -4.67 -4.28
Interest Income (Expense), Net Non-Operating -0.001 -0.006 -0.006 0 0.001
Other, Net -2.742 1.632 0.244 3.829 -1.648
Net Income Before Taxes -9.224 -9.483 -1.365 -0.841 -5.927
Net Income After Taxes -9.424 -9.483 -1.465 -0.841 -5.942
Minority Interest 2.417 2.432 0.378 0.233 1.701
Net Income Before Extra. Items -7.007 -7.051 -1.087 -0.608 -4.241
Net Income -7.007 -7.051 -1.087 -0.608 -4.241
Income Available to Common Excl. Extra. Items -7.007 -7.051 -1.087 -0.608 -4.241
Income Available to Common Incl. Extra. Items -7.007 -7.051 -1.087 -0.608 -4.241
Diluted Net Income -7.007 -7.051 -1.087 -0.608 -4.241
Diluted Weighted Average Shares 66.9428 66.719 61.0733 58.6151 56.4725
Diluted EPS Excluding Extraordinary Items -0.10467 -0.10568 -0.0178 -0.01037 -0.0751
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.10467 -0.10568 -0.0178 -0.01037 -0.0751
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Total Current Assets 15.621 7.215 2.838 3.473 20.362
Cash and Short Term Investments 13.415 5.747 1.777 1.683 11.758
Cash & Equivalents 13.415 5.747 1.777 1.683 11.758
Total Receivables, Net 0.057 0.158 0.005 0 8
Accounts Receivable - Trade, Net 0.057 0.158 0.005 0 8
Prepaid Expenses 1.914 0.939 0.806 0.666 0.442
Total Assets 25.474 14.789 9.266 8.559 27.917
Property/Plant/Equipment, Total - Net 0.68 0.849 1.004 0.07 0.283
Property/Plant/Equipment, Total - Gross 0.985 1.065 1.152 8.501 9.399
Accumulated Depreciation, Total -0.305 -0.216 -0.148 -8.431 -9.116
Other Long Term Assets, Total 0 2.944 2.536 4.792
Total Current Liabilities 8.498 6.39 13.381 18.837 26.929
Accounts Payable 1.876 1.925 2.232 2.899 2.269
Payable/Accrued
Accrued Expenses 6.331 4.35 4.946 4.803 11.632
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0.035 0.031 0.031 1.752 8.757
Total Liabilities 35.214 94.891 58.289 91.412 178.964
Total Long Term Debt 0 0 0 6.33 15.316
Long Term Debt 0 6.33 15.316
Minority Interest 24.962 83.895 40.183 62.482 131.44
Other Liabilities, Total 1.754 4.606 4.725 3.763 5.279
Total Equity -9.74 -80.102 -49.023 -82.853 -151.047
Common Stock 0.901 0.773 0.641 0.435 0.329
Additional Paid-In Capital 238.193 209.161 183.858 150.595 127.682
Retained Earnings (Accumulated Deficit) -248.834 -290.036 -233.522 -233.883 -279.058
Total Liabilities & Shareholders’ Equity 25.474 14.789 9.266 8.559 27.917
Total Common Shares Outstanding 90.0366 77.1449 64.0127 43.4413 32.8125
Other Current Assets, Total 0.235 0.371 0.25 1.124 0.162
Long Term Investments 9.173 6.725 2.48 2.48 2.48
Current Port. of LT Debt/Capital Leases 0.256 0.084 6.172 9.383 4.271
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Total Current Assets 13.612 15.621 22.171 11.272 9.221
Cash and Short Term Investments 12.138 13.415 19.566 10.835 8.449
Cash & Equivalents 12.138 13.415 19.566 10.835 8.449
Total Receivables, Net 0.057 0.057 0.928 0 0.002
Accounts Receivable - Trade, Net 0.057 0.057 0.928 0 0.002
Prepaid Expenses 1.387 2.049 1.574 0.313 0.71
Other Current Assets, Total 0.03 0.1 0.103 0.124 0.06
Total Assets 20.185 25.474 31.434 21.66 16.754
Property/Plant/Equipment, Total - Net 0.634 0.68 0.724 0.766 0.808
Long Term Investments 5.939 9.173 8.539 9.622 6.725
Total Current Liabilities 12.7 8.498 5.51 5.059 5.162
Payable/Accrued 12.474 8.023 4.663 4.855 4.965
Accrued Expenses 0.191 0.184 0.176 0.169 0.162
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 0 0.256 0.636 0 0
Other Current Liabilities, Total 0.035 0.035 0.035 0.035 0.035
Total Liabilities 28.278 35.214 52.979 69.483 73.029
Total Long Term Debt 0 0 0 0 0
Minority Interest 14.367 24.962 44.61 60.19 62.647
Other Liabilities, Total 1.211 1.754 2.859 4.234 5.22
Total Equity -8.093 -9.74 -21.545 -47.823 -56.275
Common Stock 0.901 0.901 0.897 0.834 0.808
Additional Paid-In Capital 238.669 238.193 236.557 224.457 217.647
Retained Earnings (Accumulated Deficit) -247.663 -248.834 -258.999 -273.114 -274.73
Total Liabilities & Shareholders’ Equity 20.185 25.474 31.434 21.66 16.754
Total Common Shares Outstanding 90.0366 90.0366 89.565 83.2878 80.6658
  • Annual
  • Quarterly
2021 2020 2019 2018 2017
Net income/Starting Line -17.731 -12.802 -21.938 -23.845 -54.647
Cash From Operating Activities -19.308 -18 -23.018 -26.856 -44.56
Cash From Operating Activities 0.089 0.094 0.039 0.218 0.197
Non-Cash Items -1.701 -2.586 0.935 4.316 4.853
Cash Interest Paid 0.011 0.623 1.295 2.276 2.064
Changes in Working Capital 0.035 -2.706 -2.054 -7.545 5.037
Cash From Investing Activities 0 0 0.242 0.007 -0.025
Capital Expenditures 0 0 -0.07 -0.005 -0.057
Other Investing Cash Flow Items, Total 0 0 0.312 0.012 0.032
Cash From Financing Activities 26.976 19.47 22.87 16.612 7.5
Financing Cash Flow Items 0 0
Issuance (Retirement) of Stock, Net 26.804 24.426 32.943 21.5 0
Issuance (Retirement) of Debt, Net 0.172 -4.956 -10.073 -4.888 7.5
Net Change in Cash 7.668 1.47 0.094 -10.237 -37.085
Cash Taxes Paid 0.115 0 0.1 1
Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Net income/Starting Line -9.424 -17.731 -8.248 -6.783 -5.942
Cash From Operating Activities -1.021 -19.308 -12.891 -9.297 -5.299
Cash From Operating Activities 0.023 0.089 0.067 0.045 0.023
Non-Cash Items 3.218 -1.701 -1.063 -1.292 2.084
Changes in Working Capital 5.162 0.035 -3.647 -1.267 -1.464
Cash From Financing Activities -0.256 26.976 26.71 14.385 8.001
Issuance (Retirement) of Stock, Net 0 26.804 26.158 14.469 8.085
Issuance (Retirement) of Debt, Net -0.256 0.172 0.552 -0.084 -0.084
Net Change in Cash -1.277 7.668 13.819 5.088 2.702
Cash From Investing Activities 0
Capital Expenditures 0
Other Investing Cash Flow Items, Total 0
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
MacAndrews & Forbes Holdings, Inc. Holding Company 44.9246 36606212 87000 2022-05-31 LOW
G42 Investments AI Holdings RSC, Ltd. Corporation 12.7465 10386274 10386274 2022-05-31 LOW
Medpace Investors, L.L.C. Corporation 6.6241 5397529 5397529 2022-08-16 LOW
Samsara BioCapital, LLC Venture Capital 2.0072 1635509 0 2022-12-31 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.1531 939623 653 2022-12-31 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.3551 289347 -653 2022-12-31 LOW
Veritable, L.P. Investment Advisor/Hedge Fund 0.2981 242937 222032 2022-12-31 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.1654 134745 0 2022-12-31 LOW
Millennium Management LLC Hedge Fund 0.0786 64078 -13261 2022-12-31 HIGH
Fry (John Anthony) Individual Investor 0.0749 61000 61000 2022-11-29 LOW
Nelson (Rich S) Individual Investor 0.0736 60000 0 2022-04-04
HBKS Wealth Advisors Investment Advisor 0.0708 57694 57694 2022-12-31 MED
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.0659 53660 -185 2022-12-31 LOW
Citadel Advisors LLC Hedge Fund 0.06 48860 15848 2022-12-31 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.0498 40577 0 2022-12-31 LOW
Two Sigma Investments, LP Hedge Fund 0.0467 38052 5667 2022-12-31 HIGH
Morgan Stanley Smith Barney LLC Investment Advisor 0.041 33442 0 2022-12-31 LOW
Simon Quick Advisors, LLC Investment Advisor 0.0368 30000 0 2022-12-31 MED
Bridgeway Capital Management, LLC Investment Advisor 0.0332 27018 0 2022-12-31 LOW
Kozlov (Hersh) Individual Investor 0.0307 25000 0 2022-04-04

Mengapa memilih Capital.com? Biarlah angka kami yang berbicara.

Capital.com Group

500K+

Trader

92K+

Klien aktif per bulan

$53M+

Volume investasi per bulan

$30M+

Penarikan tiap bulan

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long
Past performance is not a reliable indicator of future results
Laba/Loss
Industry: Bio Therapeutic Drugs

3980 Premier Dr
Suite 310
HIGH POINT
NORTH CAROLINA 27265
US

Income Statement

  • Annual
  • Quarterly

People also watch

US100

12,660.30 Price
+0.780% 1D Chg, %
Biaya inap posisi Long -0.0241%
Biaya inap posisi short 0.0018%
Waktu biaya inap 21:00 (UTC)
Spread 1.8

Gold

1,978.21 Price
+0.510% 1D Chg, %
Biaya inap posisi Long -0.0086%
Biaya inap posisi short 0.0004%
Waktu biaya inap 21:00 (UTC)
Spread 0.30

Oil - Crude

70.34 Price
+0.400% 1D Chg, %
Biaya inap posisi Long -0.0170%
Biaya inap posisi short -0.0050%
Waktu biaya inap 21:00 (UTC)
Spread 0.03

BTC/USD

27,757.30 Price
+1.120% 1D Chg, %
Biaya inap posisi Long -0.0616%
Biaya inap posisi short 0.0137%
Waktu biaya inap 21:00 (UTC)
Spread 60.00

Masih mencari broker yang bisa Anda percayai?

Bergabung dengan 500.000+ trader di seluruh dunia yang telah memilih trading bersama Capital.com

1. Buat & verifikasi akun Anda 2. Lakukan deposit 3. Temukan trading Anda